http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08508509-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D455-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 1994-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08508509-A
titleOfInvention Phenylpyrrole derivatives and their use as antipsychotics
abstract (57) [Summary] Formula (I): [In the formula, R 1 represents a C 1 to 4 alkyl; R 2, R 3, R 4 and R 5 are each independently hydrogen, halogen, C 1 to 4 alkyl, C 1 to 4 alkoxy, C. 1 to 4 alkoxy C 1 to 4 alkyl, C 1 to 4 alkylsulfonyl, trifluoromethylsulfonyl, arylsulfonyl substituted optionally, good heteroarylsulfonyl substituted optionally, be optionally substituted by Good aralkylsulfonyl, optionally substituted heteroaralkylsulfonyl, nitro, cyano, amino, mono- or di-alkylamino, trifluoromethyl, trifluoromethoxy, hydroxyl, hydroxy C 1-4 alkyl, C 1- 4 alkylthio, C 1 to 4 alkanoyl, C 1 to 4 alkoxycarbonyl, aminosulfonyl or Mo, - or di C 1 to 4 alkylaminosulfonyl a either nil; or R 1 and R 2 optionally one or two C 1 to 4 alkyl group optionally substituted or may be bonded chains together - ( CH 2 ) m O p (where m is 2 to 4 and p is zero or 1); Y is of formula (α): (N and m each independently represent a group represented by 1 to 3)] and a salt thereof exhibit activity at dopamine receptors and have potential for the treatment of psychosis such as schizophrenia. Usefully.
priorityDate 1993-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13900353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453136430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448339881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86632114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451410084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420546787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23690008
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456405831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420547628
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6429122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5459110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451541399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426104773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11078059

Total number of triples: 44.